The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessAbstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Cited by
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
“As the core node that modulates the distribution of iron in different organs, hepcidin is synthesized and secreted by hepatocytes and can hinder intracellular iron export by degrading ferroportin [132, 133].”
BackgroundIron imbalance in neurodegeneration
Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02399-z · Cited by 203
“As demonstrated for systemic iron absorption [6], several studies have reported the importance of hepcidin/ferroportin (Hep/Fpn) interactions [48] in regulating these exchanges between brain tissue cells [49].”
BackgroundIron deficiency and cardiovascular disease
Savarese, G., von Haehling, S., Butler, J., Cleland, J. G. F., Ponikowski, P., & Anker, S. D. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac569 · Cited by 200
“Inflammation leads to an increased release of hepcidin, a liverexpressed type II acute phase protein and a major player in iron homeostasis.(3) Hepcidin regulates the degradation of ferroportin, a transmembrane protein which transports iron absorbed after dietary intake from the inside of the mucosal cells in the smal…”
BackgroundIron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
“While necessary for metabolism, iron is also a potent oxidant, and complex systems to regulate its uptake, storage, and bioavailability also evolved (3,4) (Figure 1).”
BackgroundIron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Sawicki, K. T., Jesus, A. D., & Ardehali, H. (2023) · Circulation Research · doi:10.1161/circresaha.122.321667 · Cited by 179
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. https://app.cochat.ai/papers/10.3390/ijms22126493
- The paper
- Nemeth, E., & Ganz, T. (2021). Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22126493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.